Background. Because the clearance of contrast from the left atrium (LA) relative to the left ventricle (LV) depends on the degree of mitral regurgitation (MR), we hypothesized that a mathematical model can be developed that would provide a quantitative estimation of MR from the washout of contrast from these chambers.
Methods

Mathematical Model
The model assumes that the relative clearance of contrast from the LV and LA indicates the severity of MR. It assumes that other factors that might also affect contrast washout from these chambers, such as cardiac output, affects clearance of contrast from both chambers to similar extents. If after the contrast has been adequately mixed with blood, Cal and Cv1 are the end-systolic concentrations of contrast in the LA and LV, respectively, then the concentrations of contrast in the LA (Ca2) and LV (Cv2) at next end systole can be determined by the following equations (see "Appendix"):
where f is the forward LV ejection fraction, b is the backward LV ejection fraction, V is the ratio of LA to LV volumes, and f' is the fraction of blood going from the LA to the LV during each diastole ( Figure 1A ).
These recurring relations can be applied to data from several successive end-systolic frames to obtain optimal fits between experimental and model-derived data. The greater the number of frames available for analysis, the better is the estimation of the parameters. Because four parameters (f, b, f', and V) are used to estimate these relations, the model creates a four-dimensional matrix.
To better conceptualize this model, assume that the ratio of LA to LV volume (V) is known and these relations must be derived using only the other three parameters. In such an instance, the experimental data are fitted to the model by varying the remaining three parameters in three-dimensional space. A least-squares fit is performed at each step until an optimal fit is obtained between model-derived and experimental data ( Figure 1B Figure 1B ).
Animal Preparations
The dogs were anesthetized with 30 mg/kg sodium pentobarbital i. In group 1 dogs, a median sternotomy or a left lateral thoracotomy was performed, whereas in group 2 dogs, a median sternotomy with extension to a left thoracotomy was performed. The heart was suspended in a pericardial cradle. The proximal portions of the left anterior descending coronary artery (LAD) and left circumflex artery (LCx) were dissected free from surrounding tissues, and snares were placed loosely around them. A catheter was placed in the LA to measure LA pressure and connected to the physiological recorder via a fluidfilled transducer.
Group 1 dogs. In the nine group 1 dogs, a micromanometer-tipped catheter (model PC-484B, Millar Instruments, Houston, Tex.) was inserted into the LV cavity via a stab wound in the apex and secured in place with a purse-string suture (see Figure 2 ). This catheter was used to measure LV pressures and inject contrast into the LV cavity. The left main coronary artery was dissected free from surrounding tissues, and a snare was placed loosely around it. The right femoral artery was cannulated with a 12F catheter (Bard, USCI, Billerica, Mass.), which was attached to plastic tubing (Tygon, Norton Plastics, Akron, Ohio) placed in a constant-flow roller pump (Varistaltic Series S, Manostat Corp., New York). The other end of this tubing was connected to a Gregg cannula. After the tubing was primed with arterial blood, the tip of the Gregg cannula was inserted into the ascending aorta via an incision made in the left innominate artery, and it was advanced into the left The LA was incised, and an electromagnetic flow probe (model EP-455C, Carolina Instruments)7 was sutured to the LA wall immediately cephalad to the mitral annulus as described previously.8 The flow probe was connected to a flowmeter, which in turn was connected to the physiological recorder. Two heavy silk ties were placed around groups of mitral valve chordae tendinae and externalized through the LV free wall near the apex. The atriotomy was closed, and the dog was rewarmed, defibrillated, and weaned from cardiopulmonary bypass with the aid of an intravenous infusion of dobutamine (5 ,ug/kg . min', Eli Lilly Co., Indianapolis, Ind.).
Contrast Echocardiography
Two-dimensional echocardiographic images were obtained using 5-mHz transducers placed over the surface of the heart (Mark III, Advanced Technology Laboratories, Seattle, Wash., for the group 1 dogs; XP128, Acuson Corp., Mountain View, Calif., for the group 2 dogs). A saline-filled bath acted as an acoustic interface between the heart and the handheld transducer. To obtain optimal quality images with homogeneous brightness in the entire field, the power output settings and time-gain compensation were adjusted at the beginning of each experiment and kept constant throughout. Images were recorded on videotape using a VHS recorder (Panasonic model NV 8950, Matsushita Corp.).
Contrast was injected through the catheter positioned in the LV cavity. For the group 1 dogs, it consisted of an agitated mixture of 2 ml Renografin-76 (Squibb Diagnostics, New Brunswick, N.J.) and 2 ml saline.6 For the group 2 dogs, it consisted of 0.5 ml of albumin mi- crobubbles (450 million/ml, 4.5-gm diameter) (Albunex, Molecular Biosystems, Inc., San Diego, Calif.)9 mixed with an equal amount of saline. Images were acquired using a modified apical four-chamber view or a parasternal long-axis view.
In the group 1 dogs, the severity of MR was assessed visually by two blinded observers. It was graded on a scale of from 0 to 4+.6 If contrast never entered the LA, MR was graded as 0. If it entered the LA but cleared within 3 beats, it was graded as 1+. If it took as long for the contrast to clear from the LA as from the LV, MR was graded as 4+. Intermediate stages were graded as 2+ and 3+; half grades also were used.
An off-line image analysis computer (Mipron System, Kontron, Eching, FRG) was used for quantification of the echocardiographic data.'0 A sequence of images from just before contrast injection and until its disappearance from the LV cavity was transferred from videotape to video memory of the computer. The endsystolic frames were identified in computer memory by the observer, who then placed regions of interest over the LA and LV. To increase signal-to-noise ratio, these regions were made as large as possible while excluding surrounding structures. Figure 4 shows examples of these regions placed over images where trace (left panel) and severe (right panel) MR was noted. Plots of mean pixel intensity versus frame number then were derived for each stage.
These data were transferred to RS/1 (Bolt, Beranek, and Newman, Cambridge, Mass.) on a minicomputer (VAX 8250, Digital Equipment Corp., Maynard, Mass.). The videointensity data before the appearance of contrast were subtracted from all subsequent frames to obtain background-subtracted data. After adequate mixing of contrast and after maximal opacification of the LA and LV, an initial set of data was provided to the model to generate the succeeding values. The data were closely assessed for the occurrence of attenuation; if it occurred, only those images obtained after its disappearance were selected. From six to 12 end-systolic frames were provided for calculation, depending on the clearance rate of contrast from the LV cavity. To expedite computation of RE, the observer provided the model with a rough estimate of the LA-to-LV volume ratio (V) as assessed on echocardiography. This value was adjusted by the model by no more than +0.05 before deriving RF.
Measurement of RF
The flow signals were acquired directly onto an 80386-based personal computer (Kontron Electronics) using an eight-channel analog-to-digital convertor (DAS-16, Metrabyte Corp., Taunton, Mass.). All data were sampled at 200 Hz and formatted and displayed using Labtech Notebook (Labtech Technologies Corp., Wilmington, Mass.). These data were transferred to RS/1 for further analysis. Data also were acquired on a strip-chart recorder.
When there was no MR or only mild MR, it was easy to discern the zero-level baseline on the mitral flow signal from where the area subtended by forward flow could be measured ( Figure 5A ). In severe MR, however, the mitral flow signal appeared as a sine wave ( Figure 5B), not allowing a confident estimation of the zero-level baseline. Because the forward mitral volume minus the backward mitral volume (integral of instantaneous flow over time) equals forward aortic volume, we developed a program that used this relation to determine the zero-level baseline on the mitral flow signal. To accomplish this, the zero-level baseline was first arbitrarily adjusted below the entire mitral signal (depicted by the horizontal dashed line in Figure SC) , SVK stroke volume; MFV, mitral forward volume; MBV, mitral and the areas under the curves for mitral and aortic signals were calculated. The zero-level baseline then was automatically adjusted to a slightly higher level, and the areas under the curve were calculated again. These iterations were repeated until the forward minus the backward mitral volume equaled the forward aortic volume. The zero-level baseline was adjusted at this level (depicted as a solid horizontal line in Figure 5C ), and forward mitral volume was automatically calculated. Because the forward mitral volume includes the forward LV stroke volume as well as the regurgitant volume, RF was calculated as backward mitral volume divided by forward mitral volume.
Measurement of Hemodynamics
Hemodynamic data in the group 1 dogs were recorded at a paper speed of 100 mm/sec using a stripchart recorder. In group 2 dogs, all hemodynamic data were acquired in digital format as described above. In both groups of dogs, 10 consecutive cycles were analyzed to determine values for each stage.
Protocol
After acquiring data at baseline, different severities of MR were produced. In the group 1 dogs, MR was produced by creating varying degrees of ischemic LV dysfunction through occlusion of the LAD or LCx or by reducing left main flow.6 In the group 2 dogs, varying severities of MR were produced by creating different degrees of outward traction on the chordae tendineae or by occluding the LAD, LCx, or both. At each stage, contrast echocardiographic and hemodynamic data were acquired simultaneously. In six stages in each group of dogs, measurements were repeated for the same stage to assess reproducibility of the methods. In six stages with moderate MR in the group 2 dogs, afterload was increased by tightening the snare on the descending aorta, whereas preload was increased by infusing 300-500 ml of oxygenated blood from the bypass pump over 1 minute. At the end of the experiment, the dogs were killed.
Statistical Analysis
Data analysis was performed using RS/1.1" Data were expressed as mean +1 SD, and differences between stages were compared using ANOVA. Differences were considered significant at p<0.05 (two-sided). In the group 1 dogs, visual assessment of MR was correlated with model-derived RF using Spearman's rank correlation. In the group 2 dogs, model-derived RF was correlated with that measured from flow probes using linear regression analysis. Linear regression also was performed for estimation of reproducibility of both contrast echocardiographic and flowmetric measurements and to determine interobserver and intraobserver variabilities. Figure 6A , where the LA curve is flat and the slopes of the LA and LV curves are highly divergent, MR was graded visually as 0 and the model calculated a RF of 0. In Figure 6B , where the slopes of the curves from the LV and LA are closer and where visually MR was graded as 2.5 +, the model calculated a RF of 0.39. In Figure 6C , where the slopes of the LA and LV curves are almost identical and MR was visually assessed as 4+, the model calculated a RF of 0.62. Figure 7 illustrates the relation between the degree of MR assessed visually and the model-derived RF from 33 stages in the nine group 1 dogs. The correlation is good, the slope of the curve is not significantly different from the line of identity, and the SEE is small.
Results
Group
Group 2 Dogs
A mean of five stages (range of three to eight) was obtained in the six group 2 dogs. The hemodynamic data for different degrees of MR, arbitrarily defined based on the RF, are given in Table 2 . Despite worse hemodynamics with severe MR, unlike the group 1 dogs, the severity of MR in this group of dogs was not related primarily to a decrease in LV systolic function. Figure 8 illustrates digitally acquired aortic and mitral flow data from three different stages in one of the group 2 dogs as well as the calculated RF for each stage. The more severe was the MR, the lower was the forward aortic stroke volume. Figure 9 illustrates the relation between RF derived using the flow probes and that derived from the model from 29 stages in all six dogs. The correlation is good, the slope of the curve is not significantly different from the line of identity, and the SEE is small.
Reproducibility of the Methods
The same observer measured six duplicate data sets (flow probe and contrast echocardiography) in group 2 dogs. The model-derived RF was determined from the contrast echocardiographic data, and actual RF was calculated from the flow data. There was close reproducibility of both methods with correlation coefficients of r=0.86 and r=0.99 for contrast echocardiographically derived and flow probe-calculated RF values, respectively.
Interobserver and Intraobserver Errors
The same observer repeated measurements from six stages in both groups of dogs, whereas a second ob- Our model is based on the assumption that the relative clearance of contrast from the LV and LA is related to the severity of MR. For the model to work appropriately, it is not required that the entire LA be filled with dye in systole because a large region of interest in the LA will detect a small jet ( Figure 4A) . Similarly, the model does not depend on the degree of opacification of the LA relative to the LV. Even subtle changes in LA contrast, not visually apparent, are detected on videointensity measurements. Finally, the model is not influenced by cardiac output because it evaluates the relative clearance of contrast from both chambers. If cardiac output is low, the absolute rate of clearance of contrast from both chambers will be equally affected, whereas the relative clearance will still depend on the degree of MR.
Because in the group 1 dogs the severity of MR was related to the severity of LV dysfunction, it could be argued that we had not demonstrated that the model assessed the severity of MR independent of cardiac output. In the group 2 dogs, however, in which MR was produced by applying chordal traction (where LV function is normal) and/or by producing ischemic dysfunction (where LV function is reduced), the model accurately predicted the severity of MR, suggesting its independence from cardiac output.
This model is unique because it is developed on physiological principles and does not use a retrospective fit of data to empirically derived parameters. The model is based on indicator dilution principles and there are no "fudge factors" involved; although not tested in this study, it conceivably could be used to measure other forms of valvular regurgitation as well.
Model Limitations
Certain steps have to be taken for the model to work appropriately. First, the correct frames have to be selected, and at least six end-systolic frames are required for data fitting. The greater the number of frames, the greater will be the statistical certainty. Second, regions of interest have to be placed with care and should include as much of the LA as possible to increase the signal-to-noise ratio without encroaching on surrounding structures (Figure 4) . The model is very sensitive to noise and can produce erroneous results if the regions of interest are not placed accurately. Viewing the selected frames in cine-loop format helps to properly define the regions of interest. Alignment of images is sometimes required if significant motion artifacts are present.10 Finally, fitting the model to experimental data is computer intensive because many iterations must be performed to generate various values for each parameter. In this era, however, the need for such computational power should not be considered a serious limitation.
Critique of the Methods
Application of the mathematical model depends on a linear relation between cavitary microbubble concentration and measured videointensity. If the relation between these variables is significantly nonlinear over the range of microbubble concentrations used, then the derived RF could be inaccurate. To minimize this problem, we used microbubble concentrations sufficiently low to avoid attenuation. When attenuation was present, we selected frames after it had disappeared and confirmed the absence of attenuation from the quantitative data. We also used postprocessing curves in our echocardiographic instruments, which provided the most linear transformation of echo signal to videointensity. Consequently, we believe that for the range of bubble concentrations used in our study, the relation between microbubble-mediated backscatter and videointensity should not be a major source of error.
Stability of the contrast agent is an additional concern. Recent reports suggest that albumin microbubbles may be destroyed or altered by systolic pressures generated by the LV.12 These reports are based on peripheral venous injection of contrast, where transpulmonary transit conceivably could alter microbubble characteristics. In the present study, we did not observe less contrast effect in the LV during systole, suggesting that bubble destruction or alteration is not a significant problem when contrast is injected directly into the LV.
Other than the microbubbles themselves, the correlation of the backscatter data with flows is limited by factors such as acoustic power, carrier frequency, and postprocessing algorithms.'3 We optimized the image quality by adjusting power output and time-gain compensation at the beginning of each experiment and did not change these settings during the rest of the experi- \/%. -1' -- Because only an approximation of the ratio of LA to LV volumes is required for our model, errors introduced by actual volume measurements, required for other methods for estimating the severity of MR,4 also are avoided. After fitting the three other parameters, the model also adjusts the ratio of LA to LV volume (V) to derive RF. Providing a rough estimate of this value is, however, useful in reducing computational time.
We used electromagnetic flowmetry as the gold standard for the quantification of RF in our group 2 dogs. Despite the superiority of this technique in terms of providing actual flow information, certain limitations must be considered. If the flow is extremely eccentric, the measured flow will vary from the actual flow. MR created by global ischemia, such as in the group 1 dogs, usually is a centrally directed jet.14 Because we produced MR in the group 2 dogs by placing tension simultaneously on chordae tendineae attached to both mitral leaflets, we believe that MR in these dogs also was centrally directed.
A significant practical problem associated with the use of electromagnetic flow probes is baseline drift.15 If the signal drifts over time, determination of the timing of zero-level baseline flow is difficult, thus the measurement of forward and backward flows may be inaccurate. To overcome this problem, we used a unique computerassisted approach in which the aortic flow was used to determine where the zero-level baseline flow occurred on the mitral flow signal. Because the forward aortic flow volume is equal to the forward minus the backward mitral flow volume, forward aortic flow signals can be used to determine the timing of zero-level baseline mitral flow ( Figure 5 ). In the study dogs, there was no aortic regurgitation, so zero-flow baseline was easy to determine on the aortic flow signal (Figure 8) The imaging and quantification of regurgitant flows rather than spatial velocity patterns also should allow contrast echocardiography to be less dependent on variables such as orifice geometry and machine settings. Although this technique has been attempted previously for the assessment of MR,24,25 it has been used qualitatively in a manner similar to cineangiography.
Clinical Implications
It is sobering to realize that no method used clinically to assess the severity of MR, including cineangiography, has been validated in vivo against actual measurements of flows or RF. Our model provides an opportunity to quantitate MR using almost any method that is based on indicator dilution principles. As such, direct LV injection of contrast during two-dimensional echocardiography can be performed in the catheterization laboratory24 or the operating room25 to assess the severity of MR. This technique may find particular application in patients with renal disease, those with allergies to dyes, and those with poor LV function. The same principles also can be applied to data obtained during cineangiography.
The LV now can be opacified from a venous injection of contrast.26,27 It is thus possible that contrast echocardiography could provide an estimation of the severity of MR during routine echocardiographic examinations. The mathematical model used would obviously be different and more complex than our current model, but the principles would remain the same. It is in this regard that the application of a mathematical model for the estimation of the severity of MR during contrast echocardiography appears particularly promising.
